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Abstract
Background: There are increasing data regarding Terrisporobacter glycolicus as an emerging anaerobic pathogen.
However, the few published cases to date usually report it as part of a polymicrobial infection. Here, we describe
the first reported monomicrobial surgical site infection with this bacterium. Identification methods, taxonomy, and
clinical management of this rarely identified pathogen are also discussed.
Case presentation: A previously healthy 66-year-old sustained an open olecranon fracture of his left arm after
trauma. He subsequently underwent open reduction and internal fixation (ORIF), with insertion of an olecranon
locking plate and two locking screws. Ten days after surgery, the patient developed increasing pain at the surgical
site and noted green discharge from the wound. Culture of the wound discharge yielded grew a pure Gram-
positive anaerobe identified by the RapidANA® microbial identification system as C. difficile (profile 000010, 99.1 %
probability). Reference laboratory testing identified the isolate as T. glycolicus/mayombei (previously designated as
Clostridium glycolicum/mayombei) by 16S rRNA gene sequencing and as Clostridium glycolicum by MALDI-TOF mass
spectrometry. The patient received an 8-week course of moxifloxacin and metronidazole with an excellent clinical
response at 12 months’ follow-up.
Conclusions: We describe the case of a deep surgical site infection with T. glycolicus/mayombei (formerly known as
Clostridium glycolicum and Clostridium mayombei, respectively), which extends our knowledge of the clinical
spectrum of this pathogen. The isolate was misidentified by phenotypic identification methods.
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Background
Clostridium spp. are a heterogeneous group of anaerobic,
spore-forming, gram-positive rod-shaped bacteria. Over
200 distinct species have been identified, most of which are
environmental organisms; few species have been recog-
nized to cause clinical disease [1]. There are increasing data
regarding Terrisporobacter glycolicus & Terrisporobacter
mayombei as emerging anaerobic pathogens, yet relatively
little is known about their pathogenic potential. Previous
case reports of C. glycolicum (the former designation of T.
glycolicus) identified the bacteria in cultures of wounds and
blood, often in conjunction with other pathogens [2–4].
Although it has been implicated in bloodstream infections,
brain abscesses as well as bone and joint infections, its
ideal method of identification has yet to be determined.
We describe the first reported monomicrobial surgi-
cal site infection with prosthetic material from T.
glycolicus/T. mayombei. Phenotypic identification sys-
tems used in our laboratory at the time of the case
identified it as C. difficile, but 16S ribosomal se-
quence analysis yielded T. glycolicus/T. mayombei
with a high degree of certainty. In addition, MALDI-
TOF MS system demonstrated the ability to correctly
identify C. glycolicum, under its former designation.
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Case presentation
A previously healthy 66-year-old man fell off of his bicycle
onto dry pavement, and sustained an open olecranon
fracture of his left arm. He subsequently underwent open
reduction and internal fixation (ORIF), with insertion of an
olecranon locking plate and two locking screws.
Chlorhexidine-based sterilizing solution and peri-operative
cefazolin were used in accordance with our institution’s
protocols. The procedure was uncomplicated and the pa-
tient was discharged home on the third post-operative day.
Ten days after surgery, the patient developed increasing
pain at the surgical site and noted green discharge from
the wound. He was re-admitted to hospital for surgical
drainage of the affected elbow, and piperacillin-tazobactam
was prescribed empirically. Culture of the wound discharge
yielded anaerobic spore-forming Gram-positive rods in
broth media and anaerobic 5 % sheep blood agar, identified
by the RapidANA® microbial identification system as C.
difficile (profile 000010, 99.1 % probability). The aerobic
cultures were negative. Given the rarity of C. difficile joint
infections [5, 6], was reported as “Clostridium species”
and the isolate was sent to the provincial reference
laboratory for speciation. Our patient did not have
any evidence of C. difficile-associated diarrhea and his
stool specimen was negative for C. difficile toxin by
PCR. He was subsequently treated with intravenous
vancomycin and oral metronidazole, pending results
of antimicrobial susceptibility testing.
At the Laboratoire de santé publique du Québec
(LSPQ), latex agglutination (Microgen Bioproducts Ltd)
yielded a positive result indicating a possible C. difficile
strain. However, according to the manufacturer package
insert, C. glycolicum is known to cross react with this
reagent. The isolate was identified as C. glycolicum by
MALDI-TOF mass spectrometry using the bioMérieux
VITEK MS system (IVD database version 2.0). The
clinical isolate, designated LSPQ-04251, was definitively
identified by 16S rRNA gene sequencing using a BigDye
method with ABI3130 XL sequencing (Applied Biosys-
tems, Foster City, CA). Pairwise nucleotide sequence
similarities of the 16S rRNA gene indicated that the
closest known relatives of the isolate were Clostridium
glycolicum (99.3 %) (recently reclassified as Terrisporo-
bacter glycolicus), and Clostridium mayombei (99.2 %)
(recently reclassified as Terrisporobacter mayombei) [7].
Based on the 16S rRNA gene sequence comparison, T.
glycolicus and T. mayombei were genetically highly
related, displaying 99.4 % sequence similarities with
0.6 % divergence. No further characterization of isolate
LSP-04251 to separate both species T. glycolicus and T.
mayombei, (requiring additional analysis of the genomic
DNA G + C content, predominant cellular fatty acids
and products from peptone yeast extract) was
performed [7].
As there is little experience with clinical infections
from these bacteria [8], we relied on minimal inhibitory
concentration (MIC) determination by Etest®, according
to the manufacturer’s application guide, to guide anti-
microbial treatment (see Table 1). Treatment was chan-
ged to oral moxifloxacin and metronidazole due to
logistical barriers to intravenous therapy in this patient
and their excellent bioavailability and bone penetration
[9, 10], for a total of 8 weeks. One year after stopping
antibiotics, the patient was well, without signs of recru-
descent infection.
Discussion
Surgical site infections are an important complication of
open fractures, and this risk is modulated by several var-
iables including the size of the wound, the complexity of
the fracture, and the presence of necrotic soft tissue
[11]. Our patient’s wound was classified as Gustilo Type
II (i.e. open fracture with a laceration <1 cm in length
without extensive soft tissue damage, flaps, or avulsions)
without severe contamination. No antimicrobial prophy-
laxis was given beyond the surgical procedure. It is most
plausible that our patient’s wound was infected with T.
glycolicum/T. mayombei at the time of his initial injury
on the pavement. Although we cannot exclude haema-
togenous seeding from the gastrointestinal tract, this
would seem unlikely given the circumstances of the acci-
dent, the organism identified and the absence of GI
symptoms or underlying disease.
Although not currently assigned formally to the family
Peptostreptococcaceae, phylogenetic analyses indicated
that the species Terrisporobacter glycolicus and T. mayom-
bei are members of the family Peptostreptococcaceae [7].
To support this classification in the family of Peptostrepto-
coccaceae, Yutin and Galpieri compared a phylogenetic
tree for a concatenated set of 50 widespread ribosomal
proteins with the trees for beta subunits of the RNA poly-
merase (RpoB) and DNA gyrase (GyrB) genes and with
the 16S rRNA-based phylogeny tree. The result of this
Table 1 Minimal inhibitory concentration (MIC; μg/mL) of the
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analysis support placement of Clostridium difficile and its
close relatives (including species of the genus Terrisporo-
bacter) within the family Peptostreptococcaceae. Hence,
some have proposed to rename C. difficile as Peptoclostri-
dium difficile, and to transfer C. glycolicum and C.
mayombei to this genus as well [1]. This taxonomic con-
troversy remains unresolved for the moment. Thus, based
on available phylogenetic data, misidentification of the iso-
late LSPQ-04251 as C. difficile by phenotypic methods is
not unexpected.
Relatively little is known about the pathogenic potential
of T. glycolicus/T. mayombei. Elsayed and Zhang first re-
ported a first case of human infection with C. glycolicum
in 2007, when a 43 year old woman developed septic
shock after a recent bone marrow transplant for relapsed
Hodgkin’s disease [2]. Their patient was found to have a
polymicrobial bactermia with C. glycolicum and Entero-
coccus spp. She received numerous antibiotics initially and
subsequently completed a two-week course of ampicillin,
gentamicin and metronidazole with a good clinical re-
sponse. In 2009, Van Leer et al. described the case of a
62 year-old gentleman who developed a brain abscess with
gas formation after otitis media, for which he treated him-
self with clay in his ear [4]. C. glycolicum was the only or-
ganism identified in the patient’s blood, but numerous
other organisms were recovered from the pus and nec-
rotic tissue from the mastoid. Their patient eventually re-
covered with residual bilateral hearing loss after surgical
debridement of the infection. In 2012, Jiang et al. reported
two cases of human infection of C. glycolicum after suffer-
ing accidental injuries. Both cases resulted in polymicro-
bial infections, with one patient developing a coagulase-
negative staphylococcal bacteremia requiring six weeks of
intravenous antibiotic therapy with vancomycin. Subse-
quently, Cai et al. described a case of a 67 year-old gentle-
man with numerous medical co-morbidities who
developed acalculous cholecystitis and was found to have
a bloodstream infection with C. glycolicum. No other
pathogens were identified and the patient responded well
to treatment with pipacillin-tazobactam.
Conclusion
We describe the first reported monomicrobial surgical
site infection from T. glycolicus/T. mayombei. Sequence
analysis of the 16S rRNA gene offers greater discrimin-
ation between genera and, in many cases, species com-
pared to the other bacterial identification methods
described in this report. However, MALDI-TOF mass
spectrometry also correctly identified C. glycolicum
under its former designation and may be a reliable iden-
tification method for these pathogens. Our case demon-
strates the limitations of phenotypic identification
systems for clostridial species, and extends our know-
ledge of the clinical spectrum of T. glycolicus/T.
mayombei. Finally, species identification for deep Gram-
positive anaerobic rod infections is pertinent because
antimicrobial susceptibility patterns may be poorly char-
acterised or variable, and mandate susceptibility testing
for rarely encountered species.
Key points
 Terrisporobacter glycolicus/Terrisporobacter
mayombi is a rare cause of clinical infection, but has
been implicated in brain abscesses, bone and joint
infections, as well as bloodstream infections.
 T. glycolicus/mayombi was misidentified as C. difficile
by phenotypic and latex agglutination testing.
Accurate identification was achieved with both 16S
rRNA gene sequence analysis and MALDI-TOF MS.
 Identification to the species level for deep Gram-
positive anaerobic rod infections is potentially
clinically pertinent, and rarely encountered spe-
cies should prompt antimicrobial susceptibility
testing.
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